Skip to main content

ABEV 6-K

Ambev S.A. (ABEV)

6-K 2026-09-09 For: 2026-09-30
View Original
Added on September 09, 2026

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of September, 2026

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From August 1^st^ to 31^st^, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 ^(1)^:

Company Name: Ambev S.A.
Group and Related Persons ( X )<br><br>Board of Directors ( )<br><br>Management ( )<br><br>Fiscal Council ( )<br><br>Technical and Consulting Committees
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 30,679,627
Transactions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume (R$) ^(3)^
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 30,679,627

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From August 1^st^ to 31^st^, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 ^(1)^:

Company Name: Ambev S.A.
Group and Related Persons ( )<br><br>Board of Directors ( X )<br><br>Management ( )<br><br>Fiscal Council ( )<br><br>Technical and Consulting Committees
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 3,501,801
ADR Common 19,790
Transactions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume (R$) ^(3)^
Shares Common N/A Removal from Office 01 414,208 0.00000 0.00
ADR Common N/A Removal from Office 01 19,790 0.00000 0.00
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 3,087,593
ADR Common 0

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From August 1^st^ to 31^st^, 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 ^(1)^:

Company Name: Ambev S.A.
Group and Related Persons ( )<br><br>Board of Directors ( )<br><br>Management ( X )<br><br>Fiscal Council ( )<br><br>Technical and Consulting Committees
Initial Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 2,500
Transactions in the month
Securities / Derivatives Securities Characteristics ^(2)^ Intermediary Operation Day Quantity Price Volume (R$) ^(3)^
Final Balance
Securities / Derivatives Securities Characteristics ^(2)^ Quantity
Shares Common 2,500
(1) When filling in the form, delete the lines that<br>do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction<br># 44/2021, send a statement with that information.
--- ---
(2) Issue/Series, convertibility, simple, term, guaranties,<br>type/class, among others.
--- ---

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September 9, 2026

AMBEV S.A.
By: /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
Guilherme Fleury de Figueiredo Ferraz Parolari<br><br>Chief Financial and Investor Relations Officer